Potential drug interactions with oral anticoagulants among atrial fibrillation patients

Back

EHRA Premium Access

Potential drug interactions with oral anticoagulants among atrial fibrillation patients

Session: Poster session 1 - Atrial fibrillation - Clinical

Topic: Atrial Fibrillation - Stroke Prevention - Oral Anticoagulation

Speaker: Doctor I. Pupkevica (Riga, LV)

Event: EHRA 2018

Congress Presentation

Add to my library

About the speaker

Doctor Irina Pupkevica

Paul Stradins Clinical University Hospital, Riga (Latvia)

0 follower

28 more presentations in this session

Epworth sleepness scale and Berlin questionnaire: A comparison in a Tunisian population with non valvular atrial fibrillation

Speaker: Doctor S. Ouali (Tunis, TN)

Access

Abstract

Slides

Hypertension and atrial fibrillation: an association that increases the risk of developing obstructive sleep apnea in a Tunisian population

Speaker: Doctor S. Ouali (Tunis, TN)

Access

Abstract

Slides

Left atrial pressure correlates with atrial sphericity but not with the degree of atrial dilatation and scar burden, in patients who underwent pulmonary vein isolation.

Speaker: Doctor A. Margulescu (Swansea, GB)

Access

Abstract

Slides

AF type and low voltage areas: biomarkers distinguish AF progression phenotypes

Speaker: Associate Professor J. Kornej (Boston, US)

Access

Abstract

Triple therapy is superior to dual anti-platelet therapy in atrial fibrillation patients experiencing acute myocardial infarction with percutaneous coronary intervention

Speaker: Associate Professor K. Lee (Gwangju, KR)

Access

Abstract

Slides

Access the full session

Poster session 1 - Atrial fibrillation - Clinical

Speakers: Doctor I. Pupkevica, Doctor S. Ouali, Doctor S. Ouali, Doctor A. Margulescu, Associate Professor J. Kornej...

Access

About the event

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources